SuperbCrew, a business news website dedicated to covering innovative companies in the tech and business fields, recently interviewed Asymmetrex CEO James L. Sherley.
Dr. Sherley discusses Asymmetrex’s background, his personal background, and the newly developed algorithms for rapid low cost counting of therapeutic tissue stem cells.
“Together AlphaSTAR and Asymmetrex solve the 6 decades unsolved tissue stem cell counting problem. Our AlphaSTEM Test™ technology can count any type of human tissue stem cell that can be grown in culture.”
Read the full SuperbCrew Q&A here!
Leave a Reply